How Ozempic Maker Novo Nordisk Lost Its Shine

Start

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.

Previous Story

Lawrence A. Bossidy, Who Led a Major Corporate Turnaround, Dies at 90

Next Story

Pill Causes Major Weight Loss in Eli Lilly Trial’s Results